Nantes University Hospital
Nantes, Loire-Atlantique, 44093, France
NCT Number: NCT04798794
Investigation of the association between PaCO2 change after extra corporeal membrane oxygenation (ECMO) initiation and neurological outcome and mortality in neonates treated by ECMO for respiratory failure.
Looking for future studies?
Notify Me1 day–28 day
All sexes
Observational
Nantes, Loire-Atlantique, 44093, France
Retrospective analysis of the ELSO database investigating the association between the change of PCO2 value after ECMO start and the risk of acute neurological event under ECMO defined by the onset of cerebral bleeding and/or ischemic stroke and/or clinical or electrical seizure and/or brain death.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Neonates (<28 j) supported by ECMO for severe respiratory failure
Time frame: Up to 90 days after ECMO initiation
Onset of cerebral bleeding and/or ischemic stroke and/or clinical or electrical seizure and/or brain death. The outcome (ANE) was defined by the occurrence of almost one of the following item:
Time frame: 28 days after ECMO start
Newborns died after 28 days despite ECMO assistance
Nantes University Hospital
Other
Association Between Early Change in PaCO2 After ECMO Initiation and Neurological Outcome in Newborns
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07376525
Mechanical Ventilation, Respiration Disorders
Istanbul, Sisli, Turkey (Türkiye)
View Trial DetailsNCT07411976
Critical Illness, Disease Attributes
Nîmes, France
View Trial DetailsNCT07658131
Critical Illness, Disease Attributes
Taichung, Taiwan
View Trial DetailsNCT07620912
Chronic Disease, Chronic Obstructive Pulmonary Disease
Asyut, Egypt
View Trial Details